What’s 340B? An economist’s view of the recent wave of 340B litigation
But this change has led to complex relationships among pharmaceutical manufacturers, hospitals, pharmacies, and third-party administrators, increasing...
This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
But this change has led to complex relationships among pharmaceutical manufacturers, hospitals, pharmacies, and third-party administrators, increasing...
The issue is especially timely given provisions in the EU’s Digital Markets Act (DMA) designed to expand access to data held by large digital platforms. The...
CRA is a proud sponsor of the forum dedicated to bringing together claimant and defendant expert insights on EU competition litigation. Sebastian Panthöfer is...
CRA is a proud sponsor of the conference. Alison Hole is a panelist during the session titled “Evolving Approaches to Merger Control in Digital and...